Literature DB >> 3403832

Increased intracranial pressure elicits hypertension, increased sympathetic activity, electrocardiographic abnormalities and myocardial damage in rats.

R J Shanlin1, M J Sole, M Rahimifar, C H Tator, S M Factor.   

Abstract

Intracranial pressure was increased in 59 rats by inflating a subdural balloon to a total mass volume of 0.3 ml. The increase in intracranial pressure ranged from 75 to greater than 500 mm Hg. With few exceptions, mean arterial pressure increased to as high as 227 mm Hg during the increase in intracranial pressure. Significant increases in plasma catecholamines, major electrocardiographic changes and a considerably shortened survival time were observed only in the rats that demonstrated an increase in mean arterial pressure greater than 50 mm Hg. A perfusion study with liquid silicone rubber (Microfil) revealed dilated irregular myocardial vessels with areas of focal constriction consistent with microvascular spasm. Histologic examination of the myocardium revealed widespread patches of contraction band necrosis and occasional contraction bands in the smooth muscle media of large coronary arteries. These observations suggest that myocardial damage after suddenly increased intracranial pressure resulted both from exposure to toxic levels of catecholamines and from myocardial reperfusion. Extension of these studies to humans suggests that a detailed assessment of myocardial function should be performed in victims of severe brain injury. Myocardial dysfunction may be a major determinant of the patient's prognosis or may render the heart unsuitable for transplantation.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3403832     DOI: 10.1016/s0735-1097(88)80065-2

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  9 in total

1.  Neurogenic pulmonary edema and other mechanisms of impaired oxygenation after aneurysmal subarachnoid hemorrhage.

Authors:  Paul M Vespa; Thomas P Bleck
Journal:  Neurocrit Care       Date:  2004       Impact factor: 3.210

2.  Left Ventricular Function in the Initial Period After Severe Traumatic Brain Injury in Swine.

Authors:  Adeyinka Adedipe; Alexander St John; Vijay Krishnamoorthy; Xu Wang; Dominik T Steck; Renata Ferreira; Nathan White; Susan Stern
Journal:  Neurocrit Care       Date:  2022-03-21       Impact factor: 3.532

3.  Verapamil ameliorates the clinical and pathological course of murine myocarditis.

Authors:  R Dong; P Liu; L Wee; J Butany; M J Sole
Journal:  J Clin Invest       Date:  1992-11       Impact factor: 14.808

Review 4.  Brain-heart interactions. The neurocardiology of arrhythmia and sudden cardiac death.

Authors:  A M Davis; B H Natelson
Journal:  Tex Heart Inst J       Date:  1993

5.  Preliminary report on cardiac dysfunction after isolated traumatic brain injury.

Authors:  Sumidtra Prathep; Deepak Sharma; Matthew Hallman; Aaron Joffe; Vijay Krishnamoorthy; G Burkhard Mackensen; Monica S Vavilala
Journal:  Crit Care Med       Date:  2014-01       Impact factor: 7.598

6.  Cerebrogenic tachyarrhythmia in acute stroke.

Authors:  As Praveen Kumar; E Babu; Dk Subrahmanyam
Journal:  J Neurosci Rural Pract       Date:  2012-05

7.  Myocardial function at the early phase of traumatic brain injury: a prospective controlled study.

Authors:  Adrien Cuisinier; Claire Maufrais; Jean-François Payen; Stephane Nottin; Guillaume Walther; Pierre Bouzat
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2016-10-28       Impact factor: 2.953

Review 8.  Primary graft dysfunction after heart transplantation: a thorn amongst the roses.

Authors:  Sanjeet Singh Avtaar Singh; Jonathan R Dalzell; Colin Berry; Nawwar Al-Attar
Journal:  Heart Fail Rev       Date:  2019-09       Impact factor: 4.214

9.  Electrocardiographic abnormalities in acute cerebrovascular events in patients with/without cardiovascular disease.

Authors:  Mansoureh Togha; Alireza Sharifpour; Haleh Ashraf; Mansour Moghadam; Mohammad Ali Sahraian
Journal:  Ann Indian Acad Neurol       Date:  2013-01       Impact factor: 1.383

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.